Clinical trials
Phase 2 Hyperglycemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intermountain Health Care, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Albert Einstein College of Medicine | 1 |
| Bastyr University | 1 |
| Columbia University | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Kathleen Dungan | 1 |
| Metabolic Solutions Development Company | 1 |
| Montefiore Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 19 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 6 |
| Insulin Resistance | 3 |
| Obesity | 3 |
| Critical Illness | 2 |
| Heart Failure | 2 |
| Hypercholesterolemia | 2 |
| Hypertension | 2 |
| Hypoglycemia | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.